Phase 4 — Post-approval study. The treatment has been approved, but researchers continue monitoring it in a large population over time.
Trial locations(19 sites)
Austria
Ordensklinikum Linz, Linz Medical University Vienna, Vienna Czechia
Fakultní Nemocnice Olomouc, Olomouc Všeobecná fakultní nemocnice v Praze, Prague France
Hôpital Bicêtre-- Assistance Publique Hopitaux de Paris, Paris Hôpitaux Universitaires de Strasbourg, Strasbourg Germany
DRK Kliniken Berlin Westend, Berlin University Hospital Carl Gustav Carus of Technical University Dresden, Dresden Universitätsmedizin Greifswald, Greifswald Hungary
Gottsegen National Cardiovascular lnstitute, Budapest Medical University of Szeged, Szeged Italy
Sapienza University of Rome, Rome Poland
John Paul II Hospital Krakow, Krakow Fryderyk Chopin Hospital in European Health Centre Otwock, Otwock Portugal
Centro Hospitalar Lisboa Norte - Santa Maria University Hospital, Lisbon Romania
Emergency Institute for Cardiovascular Diseases Prof. Dr. C.C.Iliescu, Bucharest Emergency Clinical County Hospital of Targu Mures, Târgu Mureş Spain
Hospital Clinic of Barcelona, Barcelona Hospital Ramon y Cajal, Madrid